TCBP Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference

EDINBURGH, Scotland, Sept. 5, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications today announced it will participate at the H.C. Wainwright 26th Annual Global Investment Conference from September 9–11, 2024 in New York City. The in-person venue for the event is the Lotte New York Palace Hotel in New York City located at 455 Madison A ...